News
| Feb 10 | Final Glance: Medical Devices companies |
| Feb 10 | BARD C R INC /NJ/ Files SEC form 8-K, Change in Directors or Principal Officers |
| Feb 10 | Notable Call Options Activity in C. R. Bard Benzinga |
| Feb 10 | HIGH $CALL VOLU $STX 10090% $BMS 6494% $BPL 3493% $AFL 2714% $DD 2189% $BCR 1938% $SPG 1899% $SUN 1897% $VLO 1890% $ED 1265% by livevol_pro |
| Feb 10 | Midday Glance: Medical Devices companies |
| Feb 10 | IV30(TM) GAINER $BKD +24.86% $SDRL +17.09% $PPO +16.91% $RVBD +16.68% $LNG +16.56% $EWY +16.11% $STD +15.78% $BCR +15.64% $PBR +14.73% by livevol_pro |
| Feb 10 | HIGH $CALL VOLU $BMS 3894% $AFL 2582% $BCR 1863% $VLO 1502% $SUN 1304% $DD 1170% $PETM 916% $EQT 829% $EXC 736% $TGT 638% by livevol_pro |
| Feb 10 | Bard Wins Ruling Upholding $371 Million Award Against Gore |
| Feb 10 | Court upholds $371 million CR Bard patent award |
| Feb 10 | $BCR 200 Day SMA Cross - Price crossed below 200 day SMA (95.0254). Confirmed by volume. by TradeIdeasQuant |
| Feb 10 | $BCR 200 Day SMA Cross - Price crossed above 200 day SMA (95.0254). Confirmed by volume. by TradeIdeasQuant |
Profile
Exchange: NYSE Sector: Healthcare Industry: Medical Instruments & Supplies
C. R. Bard, Inc., now branded simply as Bard, is a leading multinational developer, manufacturer, and marketer of innovative, life-enhancing medical technologies in the fields of Vascular, Urology, and Oncology, and Surgical Specialty products. Bard markets its products and services worldwide to hospitals, individual health care professionals, extended care facilities, and alternate site facilities. An S&P 500 company with approximately 11,000 employees in 2009. Bard is perhaps best known for having introduced the Foley catheter in 1934. The company was founded in 1907 and is headquartered in Murray Hill, New Jersey, USA.
1 Year Total Return Performance
This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). C. R. Bard is down N/A over the last year vs S&P 500 Total Return up N/A, Baxter International up N/A, and Becton Dickinson and Company down N/A.
- BCR Total Returns
- ^SPXTR Total Returns
- BAX Total Returns
- BDX Total Returns
Fundamentals
Fundamental analysis of a business involves analyzing its financial statements and health, its management and competitive advantages. The key financial statements of a company are the income statement, balance sheet and cash flow statement.
Cash Flow Statement View Statement
You may also be interested in these BCR related companies
Pro Strategies Featuring BCR
Did C. R. Bard make it into our Pro Portfolio Strategies?
BCR Charts
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
Other BCR Resources
- Company Website
- Wiki Page
- Investor Relations
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Quote.com
- Institutional Ownership MSN Money
- SEC Filings SEC
- Technical Charts Chart.ly
- Trading Ideas Benzinga
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| BCR | 95.67 | 3.36 | 3.64% | 8.21B |
| FRT | 95.19 | -0.77 | -0.80% | 5.98B |
| WLT | 70.51 | -2.94 | -4.00% | 4.40B |
| HIW | 32.82 | -0.57 | -1.71% | 2.38B |
| BDN | 11.39 | 0.03 | 0.26% | 1.54B |
| CBL | 18.13 | 0.05 | 0.28% | 2.69B |
| PCL | 39.18 | -0.17 | -0.43% | 6.32B |
| CPT | 62.86 | -0.55 | -0.87% | 4.49B |
